The present invention relates to novel antagonizing antibodies for CD73. The invention also relates to nucleic acids encoding such antibody molecules； to methods for preparing such antibody molecules； to host cells expressing or capable of expressing such antibody molecules； to compositions comprising such antibody molecules； and to uses of such antibody molecules or such compositions, in particular for therapeutic purposes in the field of cancer diseases.本發明係關於CD73之新穎拮抗抗體。本發明亦關於編碼該等抗體分子之核酸；製備該等抗體分子之方法；表現或能夠表現該等抗體分子之宿主細胞；包括該等抗體分子之組合物；及該等抗體分子或該等組合物之用途，尤其用於癌症疾病領域中之治療目的。
